A detailed history of Van Eck Associates Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Van Eck Associates Corp holds 780,186 shares of JNJ stock, worth $114 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
780,186
Previous 692,079 12.73%
Holding current value
$114 Million
Previous $101 Million 27.92%
% of portfolio
0.16%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$145.48 - $167.38 $12.8 Million - $14.7 Million
88,107 Added 12.73%
780,186 $129 Million
Q2 2024

Jul 31, 2024

BUY
$144.38 - $157.78 $4 Million - $4.37 Million
27,692 Added 4.17%
692,079 $101 Million
Q1 2024

Apr 30, 2024

BUY
$155.22 - $162.74 $11.6 Million - $12.2 Million
74,871 Added 12.7%
664,387 $105 Million
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $5.23 Million - $5.71 Million
35,921 Added 6.49%
589,516 $92.4 Million
Q3 2023

Nov 08, 2023

BUY
$155.75 - $174.48 $4.65 Million - $5.21 Million
29,871 Added 5.7%
553,595 $86.2 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $7.4 Million - $7.97 Million
-47,963 Reduced 8.39%
523,724 $86.7 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $10.6 Million - $12.6 Million
-69,873 Reduced 10.89%
571,687 $88.6 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $10.8 Million - $12.1 Million
-67,347 Reduced 9.5%
641,560 $113 Million
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $21.1 Million - $23.4 Million
130,549 Added 22.57%
708,907 $116 Million
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $13 Million - $14.4 Million
77,489 Added 15.47%
578,358 $103 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $4.55 Million - $5.17 Million
28,786 Added 6.1%
500,869 $88.8 Million
Q4 2021

Jan 26, 2022

BUY
$155.93 - $173.01 $8.61 Million - $9.56 Million
55,243 Added 13.25%
472,083 $80.8 Million
Q3 2021

Nov 03, 2021

BUY
$161.5 - $179.47 $10.1 Million - $11.2 Million
62,405 Added 17.61%
416,840 $67.3 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $2.6 Million - $2.79 Million
16,302 Added 4.82%
354,435 $58.4 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $7.02 Million - $7.82 Million
45,879 Added 15.7%
338,133 $55.6 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $3.59 Million - $4.12 Million
26,163 Added 9.83%
292,254 $46 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $4.38 Million - $4.79 Million
31,166 Added 13.27%
266,091 $39.6 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $4.65 Million - $5.61 Million
36,084 Added 18.15%
234,925 $33 Million
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $510,466 - $707,276
4,593 Added 2.36%
198,841 $26.1 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $16.9 Million - $19.4 Million
132,573 Added 214.95%
194,248 $28.3 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $131,393 - $147,114
1,035 Added 1.71%
61,675 $7.98 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $826,769 - $909,288
-6,304 Reduced 9.42%
60,640 $8.45 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $6.97 Million - $7.75 Million
-55,457 Reduced 45.31%
66,944 $9.36 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $953,115 - $1.15 Million
-7,759 Reduced 5.96%
122,401 $15.8 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $1.75 Million - $2.06 Million
-14,413 Reduced 9.97%
130,160 $18 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $5.68 Million - $6.27 Million
47,551 Added 49.01%
144,573 $17.5 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $210,293 - $249,023
1,681 Added 1.76%
97,022 $12.4 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $1.29 Million - $1.41 Million
-9,803 Reduced 9.32%
95,341 $13.3 Million
Q3 2017

Nov 09, 2017

SELL
$129.47 - $135.38 $9.74 Million - $10.2 Million
-75,195 Reduced 41.7%
105,144 $13.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
180,339
180,339 $23.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.